Dr. Amir Iravani, MD
Claim this profileWashington University School of Medicine at Barnes-Jewish Hospital
Affiliated Hospitals
Washington University School Of Medicine At Barnes-Jewish Hospital
Fred Hutchinson Cancer Center
Clinical Trials Amir Iravani, MD is currently running
177Lu-PSMA-617
for Prostate Cancer
This phase II trial tests how well 177Lu-PSMA-617 works in treating patients with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic) and that remains despite treatment (resistant). Lutetium Lu 177 (177Lu), the radioactive (tracer) component being delivered by prostate-specific membrane antigen (PSMA)-617, has physical properties that make it ideal radionuclide (imaging tests that uses a small dose tracer) for treatment of metastatic castrate-resistant prostate cancer (mCRPC). 177Lu-PSMA-617 works by binding to prostate cancer cells and inducing damage to deoxyribonucleic acid (DNA) inside prostate cancer cells. Giving 177Lu-PSMA-617 may improve treatment outcomes for patients with mCRPC.
Recruiting
1 award
Phase 2
12 criteria
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting
2 awards
Phase 3
12 criteria
More about Amir Iravani, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Amir Iravani, MD has experience with
- Lutetium Lu 177-PSMA-617
- 64Cu-SAR-bisPSMA
- 67Cu-SAR-bisPSMA
- RYZ101
Breakdown of trials Amir Iravani, MD has run
Neuroendocrine Tumors
Carcinoid Tumor
Pancreatic Cancer
Carcinoid Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amir Iravani, MD specialize in?
Amir Iravani, MD focuses on Prostate Cancer and Neuroendocrine Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Amir Iravani, MD currently recruiting for clinical trials?
Yes, Amir Iravani, MD is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Amir Iravani, MD has studied deeply?
Yes, Amir Iravani, MD has studied treatments such as Lutetium Lu 177-PSMA-617, 64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA.
What is the best way to schedule an appointment with Amir Iravani, MD?
Apply for one of the trials that Amir Iravani, MD is conducting.
What is the office address of Amir Iravani, MD?
The office of Amir Iravani, MD is located at: Washington University School of Medicine at Barnes-Jewish Hospital, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine at Barnes-Jewish Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.